National HIV/AIDS Programme Coordinator Julie Frampton said the introduction of a vaginal gel to reduce the spread of the deadly disease is good news.
A new topical gel has been shown to reduce the rate of HIV infection by nearly 50 per cent in women, according to a study being presented at the International AIDS Conference in Vienna.
The gel contains the antiretroviral drug tenofovir, which prevents the virus from multiplying.
Frampton said the HIV/AIDS unit will work towards introducing the gel to Dominica.
“Anything new that’s good and that we can use and afford will be introduced. Hopefully through the United Nations it would be made available to all countries but affordability is always an issue,” she said.
Chair of the Global Steering Committee of the World AIDS Campaign Dr. Allyson Leacock, who addressed the International AIDS Conference this month, stressed that further study of the gel is needed to confirm the study’s results.